Envoy Medical, Inc.
COCH
$1.48
$0.021.37%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 30.50% | 42.27% | 65.31% | 15.99% | -87.92% |
| Total Depreciation and Amortization | 30.08% | 55.86% | 47.12% | 57.30% | 77.33% |
| Total Amortization of Deferred Charges | 73.92% | -- | -- | -- | -- |
| Total Other Non-Cash Items | -82.69% | -91.27% | -119.09% | -68.98% | 81.58% |
| Change in Net Operating Assets | 35.10% | -201.95% | -398.65% | -507.02% | -514.38% |
| Cash from Operations | -5.02% | -196.77% | -74.76% | -102.52% | -94.11% |
| Capital Expenditure | -540.52% | -787.28% | -135.29% | 18.80% | 29.82% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -540.52% | -787.28% | -425.13% | 18.80% | 29.82% |
| Total Debt Issued | 100.00% | 25.00% | -12.50% | 10.00% | 25.00% |
| Total Debt Repaid | -62.70% | -- | -- | -- | -- |
| Issuance of Common Stock | 1,842.20% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -84.53% | -100.00% | 12,656.52% | 12,656.52% | 12,656.52% |
| Cash from Financing | -5.09% | -44.09% | 94.05% | 137.47% | 163.00% |
| Foreign Exchange rate Adjustments | -66.67% | 28.57% | 28.57% | 37.50% | 57.14% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -68.65% | -176.50% | 42,050.00% | 76,720.00% | 530.17% |